v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Edwards Lifesciences Corporation Stockholders' Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Common stock, beginning balance (in shares) at Dec. 31, 2024     654.8          
Beginning balance at Dec. 31, 2024 $ 10,062.9 $ 9,998.4 $ 654.8 $ (6,192.3) $ 2,613.4 $ 13,167.0 $ (244.5) $ 64.5
Treasury stock, beginning balance (in shares) at Dec. 31, 2024       66.2        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 356.4 358.0       358.0   (1.6)
Other comprehensive income (loss), net of tax (10.0) (10.0)         (10.0)  
Common stock issued under stock plans and other (in shares)     1.1          
Common stock issued under stock plans and other 50.7 50.7 $ 1.1   49.6      
Stock-based compensation expense 40.2 40.2     40.2      
Purchases of treasury stock (in shares)       3.5        
Purchases of treasury stock (308.6) (308.6)   $ (258.6) (50.0)      
Common stock, ending balance (in shares) at Mar. 31, 2025     655.9          
Ending balance at Mar. 31, 2025 10,191.6 10,128.7 $ 655.9 $ (6,450.9) 2,653.2 13,525.0 (254.5) 62.9
Treasury stock, ending balance (in shares) at Mar. 31, 2025       69.7        
Common stock, beginning balance (in shares) at Dec. 31, 2024     654.8          
Beginning balance at Dec. 31, 2024 10,062.9 9,998.4 $ 654.8 $ (6,192.3) 2,613.4 13,167.0 (244.5) 64.5
Treasury stock, beginning balance (in shares) at Dec. 31, 2024       66.2        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 687.9              
Common stock, ending balance (in shares) at Jun. 30, 2025     657.6          
Ending balance at Jun. 30, 2025 10,606.5 10,545.3 $ 657.6 $ (6,456.4) 2,750.0 13,858.2 (264.1) 61.2
Treasury stock, ending balance (in shares) at Jun. 30, 2025       69.7        
Common stock, beginning balance (in shares) at Mar. 31, 2025     655.9          
Beginning balance at Mar. 31, 2025 10,191.6 10,128.7 $ 655.9 $ (6,450.9) 2,653.2 13,525.0 (254.5) 62.9
Treasury stock, beginning balance (in shares) at Mar. 31, 2025       69.7        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 331.5 333.2       333.2   (1.7)
Other comprehensive income (loss), net of tax (9.6) (9.6)         (9.6)  
Common stock issued under stock plans and other (in shares)     1.7          
Common stock issued under stock plans and other 61.0 61.0 $ 1.7   59.3      
Stock-based compensation expense 37.5 37.5     37.5      
Purchases of treasury stock (5.5) (5.5)   $ (5.5)        
Common stock, ending balance (in shares) at Jun. 30, 2025     657.6          
Ending balance at Jun. 30, 2025 $ 10,606.5 10,545.3 $ 657.6 $ (6,456.4) 2,750.0 13,858.2 (264.1) 61.2
Treasury stock, ending balance (in shares) at Jun. 30, 2025       69.7        
Common stock, beginning balance (in shares) at Dec. 31, 2025 580.7   658.7          
Beginning balance at Dec. 31, 2025 $ 10,337.6 10,337.6 $ 658.7 $ (7,091.7) 2,768.4 14,240.5 (238.3) 0.0
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 78.0     78.0        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) $ 380.7 380.7       380.7    
Other comprehensive income (loss), net of tax 17.0 17.0         17.0  
Common stock issued under stock plans and other (in shares)     1.3          
Common stock issued under stock plans and other 69.0 69.0 $ 1.3   67.7      
Stock-based compensation expense 45.4 45.4     45.4      
Purchases of treasury stock (in shares)       5.0        
Purchases of treasury stock (522.2) (522.2)   $ (422.2) (100.0)      
Common stock, ending balance (in shares) at Mar. 31, 2026     660.0          
Ending balance at Mar. 31, 2026 $ 10,327.5 10,327.5 $ 660.0 $ (7,513.9) 2,781.5 14,621.2 (221.3) 0.0
Treasury stock, ending balance (in shares) at Mar. 31, 2026       83.0        
Common stock, beginning balance (in shares) at Dec. 31, 2025 580.7   658.7          
Beginning balance at Dec. 31, 2025 $ 10,337.6 10,337.6 $ 658.7 $ (7,091.7) 2,768.4 14,240.5 (238.3) 0.0
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 78.0     78.0        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) $ 622.1              
Common stock, ending balance (in shares) at Jun. 30, 2026 576.6   661.7          
Ending balance at Jun. 30, 2026 $ 10,724.9 10,618.0 $ 661.7 $ (7,668.1) 2,975.9 14,863.1 (214.6) 106.9
Treasury stock, ending balance (in shares) at Jun. 30, 2026 85.1     85.1        
Common stock, beginning balance (in shares) at Mar. 31, 2026     660.0          
Beginning balance at Mar. 31, 2026 $ 10,327.5 10,327.5 $ 660.0 $ (7,513.9) 2,781.5 14,621.2 (221.3) 0.0
Treasury stock, beginning balance (in shares) at Mar. 31, 2026       83.0        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 241.4 241.9       241.9   (0.5)
Other comprehensive income (loss), net of tax 1.7 6.7         6.7 (5.0)
Common stock issued under stock plans and other (in shares)     1.7          
Common stock issued under stock plans and other 53.9 53.9 $ 1.7   52.2      
Stock-based compensation expense 42.2 42.2     42.2      
Purchases of treasury stock (in shares)       2.1        
Purchases of treasury stock (54.2) (54.2)   $ (154.2) 100.0      
Changes to noncontrolling interest $ 112.4             112.4
Common stock, ending balance (in shares) at Jun. 30, 2026 576.6   661.7          
Ending balance at Jun. 30, 2026 $ 10,724.9 $ 10,618.0 $ 661.7 $ (7,668.1) $ 2,975.9 $ 14,863.1 $ (214.6) $ 106.9
Treasury stock, ending balance (in shares) at Jun. 30, 2026 85.1     85.1